The ISPE Boston Annual Product Show is the premier one-day biopharmaceutical show in the Northeast and the flagship event of the ISPE Boston Area Chapter. Our local New England office cleanroom experts will be at booth.
Precision Cleanrooms’ New Raleigh office will serve customers in North Carolina, South Carolina and the surrounding southeastern United States, providing turnkey cleanroom solutions and services for many industries including: pharmaceutical, biotech, medical device, and microelectronics industries.
With several recent contracts and project wins in the greater New York area, Precision Cleanrooms intends to increase staff in the New York City office to not only serve their existing customers but continue to grow as a market leader in the region. Precision Cleanrooms’ New York office will include local sales, engineering and project management, enabling Precision Cleanrooms to offer full-service turnkey capabilities for their customers, delivering cleanroom facilities with the highest levels of quality, performance, safety and service.
During the first quarter of 2021, the world’s top 10 largest chip manufacturers saw record-high revenue growth. According to the Semiconductor Industry Association (SIA), worldwide semiconductor sales totaled $123.1 billion during the first quarter of 2021, showing an increase of 3.6% over the previous quarter and 17.8% more than the first quarter of 2020.
With the unprecedented increase in new cleanroom requisitions in 2020, Precision Cleanrooms aimed to increase quality, efficiency and decrease time to commissioning, ensuring every project is on budget and exceeds customer expectations. Procore Construction Management Software has allowed Precision Cleanrooms to serve a greater number of customers all while providing the same outstanding levels of quality, safety and service.
Precision Cleanrooms recognizes an industry pattern entering into 2021…there is a clear rise in demand for rapid-deployed modular cleanrooms across the United States. Two contributing factors to this increased demand are: a surge in the developments of vaccines, therapeutics and PPE, and a general push for more domestic manufacturing.